Pharmaceutical majors roll out generic diabetes drugs – Pulse by Maeil Business News Korea

… diabetes treatments expired. The patents for AstraZeneca plc’s SGLT-2 inhibitor class diabetes treatment Forxiga (dapagliflozin) and MSD Ltd.’s …

Share on Facebook

Tweet

Follow us

Save